Also, the SHP099 target, SHP2, is phosphorylated in the CD31+ vascular endothelial cells of B16F10 tumors whereas the CD31− tumor cells are generally p‐SHP2− (Fig 1I). Here, PTPN11 is linked to neoplasm.